Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole

被引：23
|
作者：
Lupoli, G [1 ]
Nuzzo, V [1 ]
DiCarlo, C [1 ]
Affinito, P [1 ]
Vollery, M [1 ]
Vitale, G [1 ]
Cascone, E [1 ]
Arlotta, F [1 ]
Nappi, C [1 ]
机构：
[1] UNIV NAPLES FEDERICO II,DEPT MOL & CLIN ENDOCRINOL & ONCOL,NAPLES,ITALY
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 1996年 / 10卷 / 05期
关键词：
hyperthyroidism; osteoporosis; biphosphonate; osteocalcin; bone mineral density;
D O I：
10.3109/09513599609012821
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
High levels of thyroid hormones accelerate bone turnover. The aim of the present study was to evaluate the effects of treatment with alendronate in patients affected by hyperthyroidism and osteoporosis. We studied 40 hyperthyroid patients with bone loss, divided into two groups according to menopausal state. Before treatment and after 6 and 12 months, serum 1 thyroid hormones levels, sevum osteocalcin level and bone mineral density were evaluated. In all patients we observed an increase in bone mineral density after treatment with alendronate, and a corresponding decrease in serum osteocalcin level.
引用
收藏
页码：343 / 348
页数：6
相关论文
共 50 条
  • [1] TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
    Siderova, Mira
    Hristozov, Kiril
    Tsukeva, Aleksandra
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (02): : 221 - 226
  • [2] Lipid Profiles and Bone Mineral Density in Pre- and Postmenopausal Women in Korea
    Jeong, In-Kyong
    Cho, Sun Wook
    Kim, Sang Wan
    Choi, Hyung Jin
    Park, Kyong Soo
    Kim, Seong Yeon
    Lee, Hong Kyu
    Cho, Sang-Heon
    Oh, Byung-Hee
    Shin, Chan Soo
    CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (06) : 507 - 512
  • [3] Lipid Profiles and Bone Mineral Density in Pre- and Postmenopausal Women in Korea
    In-Kyong Jeong
    Sun Wook Cho
    Sang Wan Kim
    Hyung Jin Choi
    Kyong Soo Park
    Seong Yeon Kim
    Hong Kyu Lee
    Sang-Heon Cho
    Byung-Hee Oh
    Chan Soo Shin
    Calcified Tissue International, 2010, 87 : 507 - 512
  • [4] Sex steroids, bone mass, and bone loss - A prospective study of pre-, peri-, and postmenopausal women
    Slemenda, C
    Longcope, C
    Peacock, M
    Hui, S
    Johnston, CC
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) : 14 - 21
  • [5] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    A. L. Boskey
    L. Spevak
    R. S. Weinstein
    Osteoporosis International, 2009, 20 : 793 - 800
  • [6] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    Boskey, A. L.
    Spevak, L.
    Weinstein, R. S.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) : 793 - 800
  • [7] Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate
    Watts, NB
    Jenkins, DK
    Visor, JM
    Casal, DC
    Geusens, P
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (04) : 279 - 288
  • [8] The effect of body composition on bone density in pre- and postmenopausal women
    Douchi, T
    Oki, T
    Nakamura, S
    Ijuin, H
    Yamamoto, S
    Nagata, Y
    MATURITAS, 1997, 27 (01) : 55 - 60
  • [9] Difference in the effects of body composition on bone mineral density between pre- and postmenopausal women
    Ijuin, M
    Douchi, T
    Matsuo, T
    Yamamoto, S
    Uto, H
    Nagata, Y
    MATURITAS, 2002, 43 (04) : 239 - 244
  • [10] Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
    Lomax, Anna J.
    Yap, Saw Yee
    White, Karen
    Beith, Jane
    Abdi, Ehtesham
    Broad, Adam
    Sewak, Sanjeev
    Lee, Chooi
    Sambrook, Philip
    Pocock, Nicholas
    Henry, Margaret J.
    Yeow, Elaine G.
    Bell, Richard
    JOURNAL OF BONE ONCOLOGY, 2013, 2 (04): : 145 - 153
12345